Resources

At the Pericarditis Alliance, we are dedicated to the proper diagnosis and treatment of pericarditis. It is estimated that 5% of all patients visiting the emergency room with nonischemic chest pain in a given year are suffering from pericarditis.

Our goal is to educate patients and medical professionals about the diagnosis and most current treatments and protocols for pericarditis, and to better recognize complicated pericarditis cases that manifest with atypical symptoms or do not respond to NSAIDs.

This Resource Page contains helpful links for patients, physicians, and providers.

Acute pericarditis

Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis

March 18, 2021

IRAP Study

June 1, 2020

Interleukin-1 blockade for the treatment of pericarditis

June 19, 2017

2015 ESC Guidelines for Diagnosis of Pericardial Diseases

November 7, 2015

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis

July 21, 2021

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

January 7, 2021

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

November 17, 2020

The Use of Colchicine in Pericardial Diseases

December 5, 2019

Physical Activity and acute pericarditis

February 9, 2017

Acute pericarditis

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis

July 21, 2021

Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis

March 18, 2021

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

January 7, 2021

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

November 17, 2020

IRAP Study

June 1, 2020

The Use of Colchicine in Pericardial Diseases

December 5, 2019

Interleukin-1 blockade for the treatment of pericarditis

June 19, 2017

Physical Activity and acute pericarditis

February 9, 2017

2015 ESC Guidelines for Diagnosis of Pericardial Diseases

November 7, 2015